| | | | | | | | | | |
|
|
|
|
| Dockets Entered On
October 31, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2004N-0355
|
| Scientific Considerations Related to Developing Follow-on Protein Products
|
|
|
|
|
| 2004V-0537
|
| Projector for a Laser Light Show
|
|
|
|
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
| 2005P-0166
|
| to prevent the unlawful misbranding of prescription distance glasses and contact lenses
|
|
|
|
|
| 2005P-0182
|
| Withdraw April 14, 2003, Warning Letter, CBER 03-010, addressed to Terry Fredeking, President, Antibody Systems, Inc., from the Warning Letters Web Page of FDA
|
|
|
|
|
| 2005P-0282
|
| Require Health Messages on Soft Drinks
|
|
|
|
|
| 2005V-0439
|
| Laser Light Show
|
|
|
|
|
| 2004N-0355
|
| Scientific Considerations Related to Developing Follow-on Protein Products
|
|
|
|
|
| C
17
|
| Advanced Medical Technology Association (AdvaMed)
|
| Vol #:
|
| 5
|
|
|
|
|
| 2004V-0537
|
| Projector for a Laser Light Show
|
|
|
|
|
| VRA
2
|
| HFZ-200 to Tribal Existance Productions
|
| Vol #:
|
| 1
|
|
| |
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
| C 307
|
| GlaxoSmithKline (GSK)
|
| Vol #:
|
| 24
|
|
|
|
|
| C 308
|
| J. Clarke
|
| Vol #:
|
| 24
|
|
|
|
|
| C 309
|
| B. Burkett
|
| Vol #:
|
| 24
|
|
|
|
|
| C 310
|
| National Organization for Women
|
| Vol #:
|
| 24
|
|
|
|
|
| C 311
|
| J. DiGiacomo
|
| Vol #:
|
| 24
|
|
|
|
|
| C 312
|
| L. Wood
|
| Vol #:
|
| 24
|
|
|
|
|
| C 313
|
| J. Rabon
|
| Vol #:
|
| 24
|
|
|
|
|
| C 314
|
| T. Brown
|
| Vol #:
|
| 24
|
|
|
|
|
| C 315
|
| No signature
|
| Vol #:
|
| 24
|
|
|
|
|
| C 316
|
| J. Mildenberger, MS, RPh
|
| Vol #:
|
| 24
|
|
|
|
|
| C 317
|
| S. Shromich, RN
|
| Vol #:
|
| 24
|
|
|
|
|
| C 318
|
| Pharmacy Access Partnership
|
| Vol #:
|
| 24
|
|
|
|
|
| C 319
|
| Planned Parenthood Affiliates of Washington
|
| Vol #:
|
| 24
|
|
|
|
|
| C 320
|
| University of California, San Francisco (UCSF)
|
| Vol #:
|
| 24
|
|
|
|
|
| C 321
|
| S. Ashe
|
| Vol #:
|
| 24
|
|
